This module uses fundamental data of Baird Medical to approximate the value of its Beneish M Score. Baird Medical M Score tells investors if the company management is likely to be manipulating earnings. The score is calculated using eight financial indicators that are adjusted by a specific multiplier. Please note, the M Score is a probabilistic model and cannot detect companies that manipulate their earnings with 100% accuracy. Check out Baird Medical Piotroski F Score and Baird Medical Altman Z Score analysis.
Baird
Beneish M Score
Change To Inventory
Investments
Change In Cash
Free Cash Flow
Change In Working Capital
Begin Period Cash Flow
Depreciation
Capital Expenditures
Total Cash From Operating Activities
Change To Account Receivables
Net Income
Total Cash From Financing Activities
End Period Cash Flow
Total Assets
Total Current Liabilities
Total Stockholder Equity
Property Plant And Equipment Net
Retained Earnings
Accounts Payable
Cash
Non Current Assets Total
Non Currrent Assets Other
Net Receivables
Good Will
Non Current Liabilities Total
Capital Lease Obligations
Inventory
Other Current Assets
Total Liab
Net Invested Capital
Property Plant And Equipment Gross
Short Long Term Debt
Total Current Assets
Net Working Capital
Intangible Assets
Tax Provision
Net Interest Income
Interest Income
Interest Expense
Selling General Administrative
Total Revenue
Gross Profit
Operating Income
Net Income From Continuing Ops
Research Development
Cost Of Revenue
Total Operating Expenses
Reconciled Depreciation
Income Before Tax
Total Other Income Expense Net
Minority Interest
Probability Of Bankruptcy
As of January 8, 2025, Short and Long Term Debt is expected to decline to about 6 M. In addition to that, Net Debt is expected to decline to about 6.1 M.
At this time, Baird Medical's M Score is unavailable. The earnings manipulation may begin if Baird Medical's top management creates an artificial sense of financial success, forcing the stock price to be traded at a high price-earnings multiple than it should be. In general, excessive earnings management by Baird Medical executives may lead to removing some of the operating profits from subsequent periods to inflate earnings in the following periods. This way, the manipulation of Baird Medical's earnings can lead to misrepresentations of actual financial condition, taking the otherwise loyal stakeholders on to the path of questionable ethical practices and plain fraud.
The cure to earnings manipulation is the transparency of financial reporting. It will typically remove the temptation of the top executives to inflate earnings (i.e., to promote the idea of 'winning at any cost'). Because a healthy internal audit department can enhance transparency, the board should promote the auditors' access to all the record-keeping systems across the enterprise. For example, if Baird Medical's auditors report directly to the board (not management), the managers will be reluctant to manipulate simply due to the fear of punishment. On the other hand, the auditors will be free to investigate the ledgers properly because they know that the board has their back.
Baird Medical Investment Beneish M-Score Driver Matrix
One of the toughest challenges investors face today is learning how to quickly synthesize historical financial statements and information provided by the company, SEC reporting, and various external parties in order to detect the potential manipulation of earnings. Understanding the correlation between Baird Medical's different financial indicators related to revenue, expenses, operating profit, and net earnings helps investors identify and prioritize their investing strategies towards Baird Medical in a much-optimized way. Analyzing correlations between earnings drivers directly associated with dollar figures is the most effective way to find Baird Medical's degree of accounting gimmicks and manipulations.
M-Score is one of many grading techniques for value stocks. It was developed by Professor M. Daniel Beneish of the Kelley School of Business at Indiana University and published in 1999 under the paper titled The Detection of Earnings Manipulation. The Beneish score is a multi-factor model that utilizes financial identifiers to compile eight variables used to classify whether a company has manipulated its reported earnings. The variables are built from the officially filed financial statements to create a final score call 'M Score.' The score helps to identify companies that are likely to manipulate their profits if they show deteriorating gross margins, operating expenses, and leverage against growing revenue.
Reconciled Depreciation
1.13 Million
At present, Baird Medical's Reconciled Depreciation is projected to decrease significantly based on the last few years of reporting.
About Baird Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Baird Medical Investment's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Baird Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Baird Medical Investment based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Baird Medical Investment is a strong investment it is important to analyze Baird Medical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Baird Medical's future performance. For an informed investment choice regarding Baird Stock, refer to the following important reports:
You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Is Medical Equipment space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Baird Medical. If investors know Baird will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Baird Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Baird Medical Investment is measured differently than its book value, which is the value of Baird that is recorded on the company's balance sheet. Investors also form their own opinion of Baird Medical's value that differs from its market value or its book value, called intrinsic value, which is Baird Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Baird Medical's market value can be influenced by many factors that don't directly affect Baird Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Baird Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Baird Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Baird Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.